comparemela.com

Latest Breaking News On - Onxeo stock exchange - Page 1 : comparemela.com

Onxeo : changes its name and becomes Valerio Therapeutics following approval by the Annual General Meeting of June 6, 2023

All the resolutions approved by the Board of Directors were adopted Paris , June 6, 2023 - 6:30 pm CEST - Onxeo S.A. , a clinical-stage biotechnology company specializing in. | June 6, 2023

France generalRobert colemanNicolas treboutaOnxeo sa euronextEuronext growth parisAnnual general meetingValerio therapeuticOnxeo stock exchangePress releasePecializing alonx fr0010095596

Onxeo: Publication of the 2022 Annual Financial Report

Regulatory News: Onxeo S.A. , hereafter “Onxeo” or the “Company”, a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor. | April 28, 2023

France generalOnxeo sa euronextRegulatory newsEuronext growth parisOnxeo stock exchangePress releaseArgeting alonx fr0010095596

Onxeo Reports Full Year 2022 Financial Results and Provides Clinical Development Updates

Phase 1b/2 trial of AsiDNA™ in combination with olaparib in the United States in recurrent ovarian, breast and metastatic castration-resistant prostate cancer continues to enroll. | April 24, 2023

United statesSan antonioFrance generalShefali agarwalInstitut curieJulien miaraGustave roussyJudith grecietOnxeo sa euronextDanielle guyot caparrosMarie dutreix institut curieDrug administrationGilles favre toulouse cancer research centerCompany groupAnticancer therapies congressEuropean union

Onxeo will publish its full-year results on April 24, 2023

Regulatory News: Onxeo S.A. , a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response and driver oncogenes, today announced. | April 21, 2023

France generalOnxeo sa euronextRegulatory newsEuronext growth parisMonday aprilOnxeo stock exchangePress releaseOday alonx fr0010095596

Onxeo Announces That Nasdaq Approved the Delisting of Its Shares From the First North Growth Market in Copenhagen

Last day of trading on the First North Growth market on November 8, 2022 Listing on Euronext Growth Paris remains unchanged . | August 30, 2022

France generalOnxeo sa euronextNordea danmarkNordea bank abpCompany french onxeoEuroclear bankCompany danish onxeoRegulatory newsEuronext growthNasdaq first northFirst north growthCombined general meetingNasdaq copenhagenFirst northEuronext securitiesEuronext growth paris

vimarsana © 2020. All Rights Reserved.